Versant Venture AIV Holdings — 2017 Investments
6 investments dated 2017 · listed companies and verified rows first · show all
BiotechHealthtechMedical DevicesIrvine, US
Donald E. Bobo, Jr.(Executive Officer)Scott B. Ullem(Executive Officer)Larry L. Wood(Executive Officer)Huimin Wang(Executive Officer)Catherine M. Szyman(Executive Officer)Bernard J. Zovighian(Executive Officer)
Board seatWilliam J. Link· per SEC Form D · $272.4M raise · filed Feb 2017
Co-investorsALIVE Israel HealthTech Fund
RxSight develops the Light Adjustable Lens (LAL), an FDA-approved intraocular lens that surgeons can adjust after cataract surgery to fine-tune a patient's prescription once the eye has healed.
HealthtechMedical DevicesPasadena, US
Joseph Devivo(Director)James N. Adler(Director)Robert H. Grubbs(Director)Werner F. Wolfen(Director)D. Verne Sharma(Executive Officer, Director)Javier Perez-Sala(Director)
Board seatWilliam Link· per SEC Form D · $77.5M raise · filed Apr 2017
Co-investorsFlying L PartnersForesite CapitalH.I.G. CapitalH.I.G. HealthBridge PartnersLongitude CapitalRA Capital+1 more
BiotechSan Juan Capistrano, US
Hampar Karageozian(Member of Board of Managers and Chief Executive Officer)Vicken Karageozian(Member of Board of Managers and Chief Technical Officer)John Park(Executive Officer, Director)Marc D. Kirshbaum(Member of Board of Managers and Chief Operating Officer)
BoardA. Thomas Bender(Member of Board of Managers)Robert Byrnes(Member of Board of Managers)
Board seatWilliam LinkWilliam J. Link· per SEC Form D · $13.5M raise · filed Jan 2019
BiotechNewport Beach, US
Davis Corley(Executive Officer)J. Andy Corley(Executive Officer, Director, Promoter)
Board seatWilliam LinkWilliam T. Link· per SEC Form D · $15M raise · filed Jun 2022
Co-investorsMVM Life Science Partners
A healthcare company that develops and supplies medicines, including new and more affordable therapies, aiming for reliable supply of needed treatments.
BiotechHealthtechSan Francisco, US
Jeffrey Nau(Executive Officer, Director)Mark A. Murray(Executive Officer, Director)D. Michael Ackermann(Director)
BoardAli Behbahani(Director)in
Board seatWilliam J Link· per SEC Form D · $43.1M raise · filed Oct 2017
Co-investorsFlying L PartnersNew Enterprise Associates (NEA)
BiotechCopley, US
Kevin Hershfield(Executive Officer, Director)
BoardJeffry Weinhuff(Director)Tyler Stowater(Director)Richard Heinick(Director)Steve Pazol(Director)
Board seatWilliam Link· per SEC Form D · $4.6M raise · filed May 2017
Co-investorsFlying L PartnersVisionary Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.